A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services

The goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services. We will evaluate ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or videoconferencing), to increase uptake of genetic testing and identification of genetic carriers compared to usual care. Secondly, we will evaluate the advantages of videoconferencing over telephone for delivery of remote genetic services and the short-term and longitudinal outcomes of TeleGenetic services in socio-demographically diverse patients in community practices.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Adnexal Diseases Breast Diseases Breast Neoplasms Colonic Diseases Colorectal Cancer Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Endocrine Gland Neoplasms Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Gastrointestinal Diseases Gastrointestinal Neoplasms Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Gonadal Disorders Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site Ovarian Cancer Ovarian Diseases Ovarian Neoplasms Rectal Diseases Skin Diseases Skin and Connective Tissue Diseases Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Union Hospital, Elkton, Maryland, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Eligible participants will include adult men and women (aged 18 and older) who can understand and communicate in English
meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian or colorectal cancers
have insurance coverage for genetic testing.

Exclusion criteria

Under 18 years old - professional guidelines do not recommend genetic testing for cancer risk in minors.
Does not speak English.
Does not have insurance.

Treatment and study plan

Penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site

Behavioral

Baseline and follow up survey

Penn genetic counselor provides counseling and test results disclosure by telephone to patient at community site

Behavioral

Baseline and follow up surveys

Patient receives written information on how to find genetic services in their area

Behavioral

Baseline and follow up surveys

Primary outcomes

Completion of Surveys

Time frame: 3 years

Sponsors and collaborators

Lead sponsor

Abramson Cancer Center at Penn Medicine

Other

Registry information

Official study title

A Randomized Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services

Important dates

Study start: 2015
Primary completion: 2018
Study completion: 2019
First posted: Aug 7, 2015
Registry last updated: Jan 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed